Clinical Trial: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Sponsor and Collaborators
Therapeutic Advances in Childhood Leukemia Consortium
Enzon Pharmaceuticals, Inc.
Contact: Jeannette van der Giessen, BA
Contact: Elena Eckroth
Study Chair: Elizabeth Raetz, MD New York University Medical Center
Study Chair: William Carroll, MD New York University Medical Center
Next post in Leukemia Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.